en
Scientific article
English

Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents : 5-year durability

Published inClinical microbiology and infection, vol. 29, no. 12, p. 1587-1594
Publication date2023-09
Keywords
  • Antibody avidity
  • Antibody persistence
  • Ebola virus disease
  • Immunogenicity
  • Neutralizing antibodies
  • Vaccine
Citation (ISO format)
CSAKI HUTTNER, Angela et al. Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents : 5-year durability. In: Clinical microbiology and infection, 2023, vol. 29, n° 12, p. 1587–1594. doi: 10.1016/j.cmi.2023.08.026
Main files (1)
Article (Published version)
accessLevelRestricted
Secondary files (1)
Identifiers
ISSN of the journal1198-743X
27views
0downloads

Technical informations

Creation10/10/2023 10:19:26 AM
First validation02/14/2024 4:03:37 PM
Update time02/14/2024 4:03:37 PM
Status update02/14/2024 4:03:37 PM
Last indexation02/14/2024 4:03:56 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack